Clinical Trial Detail

NCT ID NCT03446417
Title A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Zeno Pharmaceuticals, Inc.
Indications

lung non-small cell carcinoma

Therapies

ZN-e4

Age Groups: adult senior

No variant requirements are available.